ACET

Adicet Bio, Inc. ACET

ACET
Adicet Bio, Inc. LITS
Lite Strategy, Inc. IOBT
IO Biotech, Inc. TCRX
TScan Therapeutics, Inc. ADAG
Adagene Inc. NRXP
NRx Pharmaceuticals, Inc. HOWL
Werewolf Therapeutics, Inc. IMUX
Immunic, Inc. ACRV
Acrivon Therapeutics, Inc. Common Stock GANX
Gain Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ACET LITS IOBT TCRX ADAG NRXP HOWL IMUX ACRV GANX
6M -34.74 % -69.09 % -73.02 % -35.64 % -2.28 % -23.92 % -58.90 % -30.19 % 52.69 % 12.04 %
YTD -7.65 % -9.09 % -24.01 % 14.22 % 4.62 % -12.60 % -13.96 % 7.27 % -19.31 % -42.92 %
1Y -44.63 % -69.09 % -36.96 % -52.64 % 4.62 % -46.24 % -58.60 % -36.59 % -64.23 % -23.42 %
3Y -94.17 % -69.09 % -79.44 % -48.45 % 6.35 % -82.91 % -84.19 % -59.39 % -84.13 % -51.73 %
5Y -96.23 % -69.09 % -96.74 % -88.90 % -93.58 % -99.30 % -96.55 % -96.64 % -88.07 % -83.79 %
10Y -99.57 % -69.09 % -96.74 % -88.90 % -93.58 % -97.61 % -96.55 % -99.81 % -88.07 % -83.79 %
From the beginning -99.57 % -69.09 % -96.74 % -88.90 % -93.58 % -97.61 % -96.55 % -99.87 % -88.07 % -83.79 %

Dividend

Adicet Bio, Inc.

Lite Strategy, Inc.